Avanos Medical, Inc.
AVNS
$24.96
$0.000.00%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 65.60M | 89.80M | 70.50M | 90.30M | 97.00M |
| Total Receivables | 103.00M | 103.80M | 111.50M | 110.20M | 104.80M |
| Inventory | 141.30M | 148.00M | 150.60M | 142.70M | 138.10M |
| Prepaid Expenses | 15.10M | 13.80M | 17.60M | 11.40M | 12.50M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 1.20M | 1.40M | -- |
| Total Current Assets | 325.00M | 355.40M | 351.40M | 356.00M | 352.40M |
|
|
|||||
| Total Current Assets | 325.00M | 355.40M | 351.40M | 356.00M | 352.40M |
| Net Property, Plant & Equipment | 150.50M | 141.00M | 145.30M | 145.40M | 141.90M |
| Long-term Investments | 394.00M | 394.90M | 394.40M | 381.20M | 455.90M |
| Goodwill | 394.00M | 394.90M | 394.40M | 381.20M | 455.90M |
| Total Other Intangibles | 114.70M | 117.80M | 122.00M | 105.40M | 107.20M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 65.70M | 64.60M | 54.60M | 51.00M | 50.40M |
| Total Assets | 1.05B | 1.07B | 1.07B | 1.04B | 1.11B |
|
|
|||||
| Total Accounts Payable | 52.30M | 55.50M | 54.20M | 48.80M | 46.00M |
| Total Accrued Expenses | 51.00M | 74.40M | 70.00M | 60.50M | 54.90M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 21.30M | 18.40M | 18.90M | 19.80M | 19.80M |
| Total Finance Division Other Current Liabilities | 6.60M | 16.90M | 4.80M | 5.50M | 16.50M |
| Total Other Current Liabilities | 6.60M | 16.90M | 4.80M | 5.50M | 16.50M |
| Total Current Liabilities | 131.20M | 165.20M | 147.90M | 134.60M | 137.20M |
|
|
|||||
| Total Current Liabilities | 131.20M | 165.20M | 147.90M | 134.60M | 137.20M |
| Long-Term Debt | 87.30M | 90.30M | 93.40M | 95.70M | 98.00M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 29.80M | 20.40M | 21.40M | 21.80M | 23.10M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 19.70M | 19.60M | 27.00M | 10.60M | 10.10M |
| Total Liabilities | 268.00M | 295.50M | 289.70M | 262.70M | 268.40M |
|
|
|||||
| Common Stock & APIC | 1.70B | 1.69B | 1.69B | 1.69B | 1.68B |
| Retained Earnings | -774.80M | -779.90M | -778.60M | -777.20M | -700.40M |
| Treasury Stock & Other | -139.60M | -134.30M | -134.60M | -133.90M | -143.50M |
| Total Common Equity | 782.10M | 778.20M | 778.00M | 776.30M | 839.40M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 782.10M | 778.20M | 778.00M | 776.30M | 839.40M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 782.10M | 778.20M | 778.00M | 776.30M | 839.40M |
|
|
|||||